188 related articles for article (PubMed ID: 9338004)
1. Gene delivery by HVJ-liposome in the experimental gene therapy of murine glioma.
Mabuchi E; Shimizu K; Miyao Y; Kaneda Y; Kishima H; Tamura M; Ikenaka K; Hayakawa T
Gene Ther; 1997 Aug; 4(8):768-72. PubMed ID: 9338004
[TBL] [Abstract][Full Text] [Related]
2. Preclinical and therapeutic utility of HVJ liposomes as a gene transfer vector for hepatocellular carcinoma using herpes simplex virus thymidine kinase.
Hasegawa H; Shimada M; Yonemitsu Y; Utsunomiya T; Gion T; Kaneda Y; Sugimachi K
Cancer Gene Ther; 2001 Apr; 8(4):252-8. PubMed ID: 11393277
[TBL] [Abstract][Full Text] [Related]
3. HVJ-liposome-mediated transfection of HSVtk gene driven by AFP promoter inhibits hepatic tumor growth of hepatocellular carcinoma in SCID mice.
Hirano T; Kaneko S; Kaneda Y; Saito I; Tamaoki T; Furuyama J; Tamaoki T; Kobayashi K; Ueki T; Fujimoto J
Gene Ther; 2001 Jan; 8(1):80-3. PubMed ID: 11402306
[TBL] [Abstract][Full Text] [Related]
4. HVJ (Sendai virus)-cationic liposomes: a novel and potentially effective liposome-mediated technique for gene transfer to the airway epithelium.
Yonemitsu Y; Kaneda Y; Muraishi A; Yoshizumi T; Sugimachi K; Sueishi K
Gene Ther; 1997 Jul; 4(7):631-8. PubMed ID: 9282164
[TBL] [Abstract][Full Text] [Related]
5. A continuous intracerebral gene delivery system for in vivo liposome-mediated gene therapy.
Zhu J; Zhang L; Hanisch UK; Felgner PL; Reszka R
Gene Ther; 1996 Jun; 3(6):472-6. PubMed ID: 8789795
[TBL] [Abstract][Full Text] [Related]
6. Cationic liposomes conjugation to recombinant adenoviral vectors containing herpes simplex virus thymidine kinase gene followed by ganciclovir treatment reduces viral antigenicity and maintains antitumor activity in mouse experimental glioma models.
Mizuno M; Ryuke Y; Yoshida J
Cancer Gene Ther; 2002 Oct; 9(10):825-9. PubMed ID: 12224023
[TBL] [Abstract][Full Text] [Related]
7. Efficient in vivo gene transfer into the heart in the rat myocardial infarction model using the HVJ (Hemagglutinating Virus of Japan)--liposome method.
Aoki M; Morishita R; Muraishi A; Moriguchi A; Sugimoto T; Maeda K; Dzau VJ; Kaneda Y; Higaki J; Ogihara T
J Mol Cell Cardiol; 1997 Mar; 29(3):949-59. PubMed ID: 9152856
[TBL] [Abstract][Full Text] [Related]
8. Widespread gene transfection into the central nervous system of primates.
Hagihara Y; Saitoh Y; Kaneda Y; Kohmura E; Yoshimine T
Gene Ther; 2000 May; 7(9):759-63. PubMed ID: 10822302
[TBL] [Abstract][Full Text] [Related]
9. Gene therapy for malignant glioma using Sindbis vectors expressing a fusogenic membrane glycoprotein.
Zhang J; Frolov I; Russell SJ
J Gene Med; 2004 Oct; 6(10):1082-91. PubMed ID: 15368589
[TBL] [Abstract][Full Text] [Related]
10. Development of HVJ envelope vector and its application to gene therapy.
Kaneda Y; Yamamoto S; Nakajima T
Adv Genet; 2005; 53():307-32. PubMed ID: 16240999
[TBL] [Abstract][Full Text] [Related]
11. In vivo gene transfer into the retina mediated by a novel liposome system.
Hangai M; Kaneda Y; Tanihara H; Honda Y
Invest Ophthalmol Vis Sci; 1996 Dec; 37(13):2678-85. PubMed ID: 8977482
[TBL] [Abstract][Full Text] [Related]
12. Use of EBV-based Vector/HVJ-liposome complex vector for targeted gene therapy of EBV-associated neoplasms.
Hirai H; Satoh E; Osawa M; Inaba T; Shimazaki C; Kinoshita S; Nakagawa M; Mazda O; Imanishi J
Biochem Biophys Res Commun; 1997 Dec; 241(1):112-8. PubMed ID: 9405242
[TBL] [Abstract][Full Text] [Related]
13. Treatment of rat experimental brain tumors by herpes simplex virus thymidine kinase gene-transduced allogeneic tumor cells and ganciclovir.
Namba H; Tagawa M; Miyagawa T; Iwadate Y; Sakiyama S
Cancer Gene Ther; 2000 Jun; 7(6):947-53. PubMed ID: 10880027
[TBL] [Abstract][Full Text] [Related]
14. Sustained transgene expression in vitro and in vivo using an Epstein-Barr virus replicon vector system combined with HVJ liposomes.
Saeki Y; Wataya-Kaneda M; Tanaka K; Kaneda Y
Gene Ther; 1998 Aug; 5(8):1031-7. PubMed ID: 10326025
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo effects of retrovirus-mediated transfer of the connexin 43 gene in malignant gliomas: consequences for HSVtk/GCV anticancer gene therapy.
Cirenei N; Colombo BM; Mesnil M; Benedetti S; Yamasaki H; Finocchiaro G
Gene Ther; 1998 Sep; 5(9):1221-6. PubMed ID: 9930323
[TBL] [Abstract][Full Text] [Related]
16. Experimental gene therapy against subcutaneously implanted glioma with a herpes simplex virus-defective vector expressing interferon-gamma.
Kanno H; Hattori S; Sato H; Murata H; Huang FH; Hayashi A; Suzuki N; Yamamoto I; Kawamoto S; Minami M; Miyatake S; Shuin T; Kaplitt MG
Cancer Gene Ther; 1999; 6(2):147-54. PubMed ID: 10195881
[TBL] [Abstract][Full Text] [Related]
17. Antitumor effect and cellular immunity activation by murine interferon-beta gene transfer against intracerebral glioma in mouse.
Natsume A; Mizuno M; Ryuke Y; Yoshida J
Gene Ther; 1999 Sep; 6(9):1626-33. PubMed ID: 10490773
[TBL] [Abstract][Full Text] [Related]
18. Gene therapy for oral cancer: efficient delivery of a 'suicide gene' to murine oral cancer cells in physiological milieu.
Young M; Overlid N; Konopka K; Düzgünes N
J Calif Dent Assoc; 2005 Dec; 33(12):967-71. PubMed ID: 16454240
[TBL] [Abstract][Full Text] [Related]
19. Novel immunotherapy for peritoneal dissemination of murine colon cancer with macrophage inflammatory protein-1beta mediated by a tumor-specific vector, HVJ cationic liposomes.
Miyata T; Yamamoto S; Sakamoto K; Morishita R; Kaneda Y
Cancer Gene Ther; 2001 Nov; 8(11):852-60. PubMed ID: 11773975
[TBL] [Abstract][Full Text] [Related]
20. Eradication of murine brain tumors by direct inoculation of concentrated high titer-recombinant retrovirus harboring the herpes simplex virus thymidine kinase gene.
Tamura K; Tamura M; Ikenaka K; Yoshimatsu T; Miyao Y; Nanmoku K; Shimizu K
Gene Ther; 2001 Feb; 8(3):215-22. PubMed ID: 11313793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
